Q3 2021 Trinity Biotech PLC Earnings Call Transcript
Good day, and welcome to the Trinity Biotech Third Quarter 2021 Financial Results Call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Joe Diaz with Lytham Partners. Please go ahead.
Thank you, operator, and thanks to all of you for joining us today to review the financial results of Trinity Biotech for the third quarter of 2021, which ended on September 30, 2021. Management will also discuss the entry into an $81.25 million loan facility to refinance substantially all of the existing $99.9 million of exchangeable senior notes issued by the company's subsidiary, Trinity Biotech Investment Limited and exchange agreements for over 99% of the outstanding convertible notes, all of which are subject to certain conditions received.
Joining us on today's call is Ronan O'Caoimh, Chairman and Chief Executive Officer; and John Gillard, Chief Financial Officer. At the conclusion of today's prepared remarks, we will open the call for a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |